Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Miraca Holdings Inc (4544) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3487
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early detection and diagnosis. Its clinical laboratory testing services include collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. Miraca Holdings provides various healthcare related services, such as sterilization, clinical trial support and preventive medicine related services. It offers sterilization services to hospitals in the Kanto, Chubu, Kansai, Chugoku and Kyushu regions. Miraca Holdings is headquartered in Tokyo, Japan.

Miraca Holdings Inc (4544) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11
Partnerships 13
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13
Baylor College to Form Joint Venture with Miraca 14
Miraca Holdings Inc – Key Competitors 15
Miraca Holdings Inc – Key Employees 16
Miraca Holdings Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11
Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13
Baylor College to Form Joint Venture with Miraca 14
Miraca Holdings Inc, Key Competitors 15
Miraca Holdings Inc, Key Employees 16
Miraca Holdings Inc, Subsidiaries 17
Miraca Holdings Inc, Joint Venture 17

List of Figures
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Miraca Holdings Inc (4544):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Madrigal Pharmaceuticals Inc (MDGL):企業の財務・戦略的SWOT分析
    Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • RainDance Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務情報
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Freshfields Bruckhaus Deringer LLP:企業の戦略・SWOT・財務情報
    Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report Summary Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務情報
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Lebara Group:企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • First Electric Cooperative Corp:企業の戦略的SWOT分析
    First Electric Cooperative Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Globe Telecom, Inc.:企業の戦略・SWOT・財務情報
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析2018
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • ManpowerGroup Inc (MAN):企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Samsung Heavy Industries Co., Ltd.
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Five Star Senior Living Inc (FVE):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Alvogen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. A …
  • Molecular Health GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Health GmbH (Molecular Health) is a biomedical company that designs, develops, manufactures and commercializes software systems which performs integrated analysis of clinical and genomic patient data to support treatment decisions and provide related services. The company offers Mo …
  • Turner Price Ltd:企業の戦略・SWOT・財務情報
    Turner Price Ltd - Strategy, SWOT and Corporate Finance Report Summary Turner Price Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • InVivoScribe Technologies Inc:企業の製品パイプライン分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent de …
  • Targa Resources Partners LP (NGLS PR A)-石油・ガス分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • JBS S.A.:戦略・SWOT・企業財務分析
    JBS S.A. - Strategy, SWOT and Corporate Finance Report Summary JBS S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆